Clinical Trials

NIAID Launches Three New AIDS Vaccine Trials

Published in Vaccine Weekly, July 3rd, 1995

Three new trials of experimental vaccines to prevent HIV infection or AIDS recently began enrolling 144 total needed volunteers, the U.S. National Institutes of Allergy and Infectious Diseases (NIAID) announced.

Volunteers are being recruited through NIAID's AIDS Vaccine Evaluation Group (AVEG), which consists of six clinical units located in St. Louis, Missouri; Nashville, Tennessee; Seattle, Washington; Birmingham, Alabama; Baltimore, Maryland; and Rochester, New York.

These new trials are among the 23 trials of 16 preventive AIDS vaccines NIAID has sponsored since 1988. "NIAID is committed to advancing the best candidate HIV vaccines into the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-07-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry